Additional Titles & Roles
- Consultation Psychiatry
Education & Training
- Residency: Johns Hopkins University, 1999
- MD: University of Kansas, 1995
- Outstanding Clinical Faculty Educator, University of Missouri School of Medicine, 2015
- Excellence in Research Mentoring, University of Missouri School of Medicin, 2015
- Winner, Eric Hoffer notable book award for “We Came in Peace for all Mankind”,
Areas of Clinical Interest
Oncology/ Breast Cancer
Extreme Overvalued Beliefs
Dr. Rahman is interested in repurposing antipsychotic drugs for cancer treatment. Antipsychotic drugs have strong preclinical evidence of anti-tumor molecular properties. Dr. Rahman and colleagues were recently awarded a Siteman Investment Program grant to conduct a large retrospective cohort pharmaco-epidemiology study on antipsychotics and breast cancer. Further studies are needed to determine if antipsychotics can play a role in the treatment of cancers.
Dr. Rahman and colleagues have recently determined that extreme overvalued beliefs are different from delusions and obsessions and that extreme violence such as terrorism and mass shootings usually stem from such beliefs. He has studied mass shootings and terrorism related to this construct. He has several publications and over 300 media placements on this topic. He is working with other terrorism and lone actor violence researchers to better define cognitive drivers of lone actor violence. Dr. Rahman conducts forensic evaluations and has been a consultant at both the State and Federal levels on issues such as insanity, competency to stand trial, death penalty mitigation and civil cases.
Dr. Rahman has also published articles on ethical issues in psychiatry including the use of pharmacogenomics tests in clinical practice and how they may raise unintended harms. He has also written a guide for clinicians to help make ethical decisions when utilizing trackable pill technology.
- Rahman T, Ash DM, Lauriello J, Rawlani R, (2017 Oct). Misleading Guidance From Pharmacogenomic Testing. Am J Psychiatry. 174(10): 922-924.
Read publication »Misleading Guidance From Pharmacogenomic Testing.
- Rahman T, Clevenger CV, Kaklamani V, Lauriello J, Campbell A, Malwitz K, Kirkland RS, (2014 Jun). Antipsychotic treatment in breast cancer patients. Am J Psychiatry. 171(6): 616-21.
Read publication »Antipsychotic treatment in breast cancer patients.
- Rahman T, Resnick PJ, Harry B, (2016 Mar). Anders Breivik: Extreme Beliefs Mistaken for Psychosis. J. Am. Acad. Psychiatry Law. 44(1): 28-35.
Read publication »Anders Breivik: Extreme Beliefs Mistaken for Psychosis.
- Rahman T, Grellner KA, Harry B, Beck N, Lauriello J, (2013 Oct). Infanticide in a case of folie à deux. Am J Psychiatry. 170(10): 1110-2.
Read publication »Infanticide in a case of folie à deux.
- Rahman T, (2019 Apr). Should Trackable Pill Technologies Be Used to Facilitate Adherence Among Patients Without Insight? AMA J Ethics. 21(4): E332-336.
Read publication »Should Trackable Pill Technologies Be Used to Facilitate Adherence Among Patients Without Insight?
- Rahman T, Meloy JR, Bauer R, (2019 May). Extreme Overvalued Belief and the Legacy of Carl Wernicke. J. Am. Acad. Psychiatry Law.
Read publication »Extreme Overvalued Belief and the Legacy of Carl Wernicke.
Funded Research Projects
Siteman Investment Program- Antipsychotics and Breast Cancer (PI)